Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 44% ± 21% | |
endothelial cell | 15 studies | 31% ± 13% | |
adipocyte | 10 studies | 90% ± 10% | |
cardiac muscle cell | 6 studies | 57% ± 24% | |
oligodendrocyte precursor cell | 6 studies | 26% ± 8% | |
fibroblast | 6 studies | 27% ± 11% | |
oligodendrocyte | 5 studies | 26% ± 7% | |
hepatocyte | 4 studies | 66% ± 25% | |
epithelial cell | 3 studies | 32% ± 12% | |
endothelial cell of vascular tree | 3 studies | 51% ± 21% | |
macrophage | 3 studies | 18% ± 2% | |
ependymal cell | 3 studies | 37% ± 10% | |
pericyte | 3 studies | 30% ± 6% | |
transit amplifying cell | 3 studies | 20% ± 6% | |
smooth muscle cell | 3 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 99% | 8311.75 | 255 / 258 | 99% | 13.04 | 228 / 230 |
liver | 98% | 12900.74 | 221 / 226 | 99% | 15.65 | 401 / 406 |
thymus | 98% | 9053.61 | 643 / 653 | 95% | 6.91 | 576 / 605 |
kidney | 94% | 5185.00 | 84 / 89 | 98% | 11.39 | 884 / 901 |
stomach | 95% | 6793.05 | 340 / 359 | 89% | 5.63 | 255 / 286 |
intestine | 98% | 11517.46 | 948 / 966 | 85% | 4.47 | 447 / 527 |
breast | 99% | 44985.58 | 455 / 459 | 84% | 7.73 | 935 / 1118 |
prostate | 91% | 5538.62 | 223 / 245 | 91% | 5.42 | 456 / 502 |
pancreas | 83% | 3576.20 | 272 / 328 | 94% | 8.72 | 168 / 178 |
ovary | 97% | 5030.93 | 174 / 180 | 74% | 3.58 | 317 / 430 |
uterus | 97% | 6295.75 | 165 / 170 | 68% | 3.60 | 313 / 459 |
esophagus | 75% | 9817.13 | 1083 / 1445 | 76% | 4.97 | 139 / 183 |
bladder | 86% | 9487.62 | 18 / 21 | 56% | 2.54 | 281 / 504 |
skin | 44% | 2510.80 | 795 / 1809 | 83% | 5.18 | 390 / 472 |
brain | 35% | 1282.67 | 914 / 2642 | 85% | 4.76 | 601 / 705 |
lung | 56% | 2401.46 | 326 / 578 | 63% | 2.92 | 726 / 1155 |
adipose | 100% | 55074.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 45920.37 | 803 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 9.36 | 75 / 80 |
heart | 92% | 9466.69 | 790 / 861 | 0% | 0 | 0 / 0 |
spleen | 74% | 3314.74 | 179 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 3.55 | 31 / 45 |
blood vessel | 53% | 3574.25 | 704 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 2.11 | 15 / 29 |
peripheral blood | 0% | 17.99 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0007584 | Biological process | response to nutrient |
GO_0031999 | Biological process | negative regulation of fatty acid beta-oxidation |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0046722 | Biological process | lactic acid secretion |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0019395 | Biological process | fatty acid oxidation |
GO_0090461 | Biological process | intracellular glutamate homeostasis |
GO_1903242 | Biological process | regulation of cardiac muscle hypertrophy in response to stress |
GO_0090459 | Biological process | intracellular aspartate homeostasis |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0051289 | Biological process | protein homotetramerization |
GO_0006084 | Biological process | acetyl-CoA metabolic process |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0060421 | Biological process | positive regulation of heart growth |
GO_0072350 | Biological process | tricarboxylic acid metabolic process |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0046323 | Biological process | glucose import |
GO_2001295 | Biological process | malonyl-CoA biosynthetic process |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0005739 | Cellular component | mitochondrion |
GO_0016507 | Cellular component | mitochondrial fatty acid beta-oxidation multienzyme complex |
GO_0005829 | Cellular component | cytosol |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0003989 | Molecular function | acetyl-CoA carboxylase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0009374 | Molecular function | biotin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACACB |
Protein name | ACACB protein Acetyl-CoA carboxylase 2 (EC 6.4.1.2) (ACC-beta) Acetyl-CoA carboxylase beta |
Synonyms | ACCB ACC2 |
Description | FUNCTION: Mitochondrial enzyme that catalyzes the carboxylation of acetyl-CoA to malonyl-CoA and plays a central role in fatty acid metabolism . Catalyzes a 2 steps reaction starting with the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain followed by the transfer of the carboxyl group from carboxylated biotin to acetyl-CoA . Through the production of malonyl-CoA that allosterically inhibits carnitine palmitoyltransferase 1 at the mitochondria, negatively regulates fatty acid oxidation (By similarity). Together with its cytosolic isozyme ACACA, which is involved in de novo fatty acid biosynthesis, promotes lipid storage (By similarity). . |
Accessions | ENST00000338432.12 [O00763-1] ENST00000536440.2 H0YGH5 ENST00000538526.5 F8W8T8 S4R3S7 ENST00000544726.2 ENST00000377848.7 [O00763-1] F5H5C3 Q4G170 O00763 A0A087WUA1 ENST00000539864.1 ENST00000377854.9 |